Adapalene

Prescription retinoid that normalizes skin cell turnover and reduces acne.

Also known as: Differin (brand name); 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid; adapalene

What it is

Adapalene is a third-generation synthetic retinoid—a vitamin A derivative—that binds selectively to retinoic acid receptors (RARs) in skin cells. Unlike tretinoin, it does not bind to retinoid X receptors (RXRs), making it more targeted and often better tolerated.

What it does

Adapalene normalizes keratinocyte differentiation and reduces sebum production, making it highly effective for acne. It also stimulates collagen remodeling and increases cell turnover, improving fine lines, texture, and post-inflammatory hyperpigmentation. The mechanism is receptor-selective, which typically causes less irritation than first-generation retinoids.

The evidence

Strong clinical evidence supports adapalene for moderate acne and comedonal acne; multiple RCTs show efficacy comparable to tretinoin with better tolerability. Moderate evidence exists for anti-aging benefits (fine lines, firmness) and post-acne marks. Evidence is emerging for melasma and photoaging when combined with sunscreen.

Best for

Acne-prone skin, oily and combination skin, and those seeking anti-aging benefits with better tolerability than tretinoin; also useful for post-acne texture and mild hyperpigmentation.

Pairs well with

Niacinamide (reduces irritation), azelaic acid (synergistic for acne and rosacea), benzoyl peroxide (acne control), sunscreen (essential). Works well in a stepwise routine after tolerance builds.

Use cautiously with

Avoid combining with other retinoids (tretinoin, retinol, retinaldehyde) to prevent excessive irritation. Use cautiously with vitamin C (L-ascorbic acid) at high pH, as it may increase irritation; separate timing or use stabilized forms. Avoid with strong exfoliants (AHAs, BHAs) during initiation phase.

Cautions

Adapalene causes photosensitivity and teratogenicity; daily SPF 30+ sunscreen is mandatory, and it is contraindicated in pregnancy. Expect retinization (redness, peeling, dryness) for 2–4 weeks; start low (0.1%) and titrate slowly. Avoid use in patients with eczema or severe baseline sensitivity without medical supervision.